Please assess the completion status of the following clinical trial:

Trial Title: Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Heightened anxiety triggered or exacerbated by COVID-19~2. Anxiety it least mild-moderate in severity~3. English speaking and living in the United States~4. Access to a smart phone, tablet, or computer with internet~5. Able to read and understand English~Exclusion Criteria:~1. Individuals with severe depression or substance abuse~2. Individuals with a current or past history of psychosis, bipolar disorder, or PTSD.~3. Individuals with physical disability that might make study participation difficult.~4. Individuals with an unstable medical illness or a history of cardiac disease~5. Individuals with a current daily practice of meditation or Kundalini yoga~6. Individuals with confirmed or suspected COVID-19~7. Individuals who are currently pregnant or anticipate being pregnant during study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Anxiety Reduction Training (A.R.T.) (Type: ACTIVE_COMPARATOR): Participants will received biweekly on-line lessons that provide education and strategies to reduce stress and disturbing thoughts and improve healthy coping and sleep. .
- ART and Kundalini Yoga (Type: EXPERIMENTAL): This combines ART with a daily 30 minute practice of Kundalini Yoga (stretching, guided breathing, and meditation). Accessible by smart phone, tablet or computer.
- ART and Meditation (Type: EXPERIMENTAL): This combines ART with a daily 15 minute meditation with stress reduction techniques and guided breathing.

Based on this trial design, predict the completion outcome and termination type (if applicable).